Search details
1.
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Lancet
; 2024 May 17.
Article
in English
| MEDLINE | ID: mdl-38772405
2.
Joint longitudinal and time-to-event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the EXSCEL trial.
Diabetes Obes Metab
; 25(5): 1261-1270, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36635232
3.
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
JAMA
; 330(15): 1459-1471, 2023 10 17.
Article
in English
| MEDLINE | ID: mdl-37847274
4.
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
Cardiovasc Diabetol
; 21(1): 182, 2022 09 13.
Article
in English
| MEDLINE | ID: mdl-36100925
5.
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis.
Ann Intern Med
; 174(1): 58-68, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32909814
6.
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?
Diabetes Obes Metab
; 22(7): 1151-1156, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32115840
7.
Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes.
Cardiovasc Diabetol
; 18(1): 135, 2019 10 17.
Article
in English
| MEDLINE | ID: mdl-31623625
8.
Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).
Diabetes Obes Metab
; 21(9): 2115-2122, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31099472
9.
Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
Circulation
; 127(9): 980-7, 2013 Mar 05.
Article
in English
| MEDLINE | ID: mdl-23362315
10.
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.
J Diabetes
; 16(2): e13473, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37915263
11.
Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.
Am Heart J
; 199: 170-175, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29754657
12.
11ß-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
Nat Commun
; 14(1): 1025, 2023 02 23.
Article
in English
| MEDLINE | ID: mdl-36823106
13.
Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89.
Diabetes Care
; 44(8): 1877-1884, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34162666
14.
Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88.
Diabetes Care
; 2021 Jul 07.
Article
in English
| MEDLINE | ID: mdl-34244332
15.
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.
J Diabetes
; 13(10): 817-826, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-33665904
16.
Refeeding risks in patients requiring intravenous nutrition support: Results of a two-centre, prospective, double-blind, randomised controlled trial.
Clin Nutr ESPEN
; 41: 143-152, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33487258
17.
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86).
Lancet Diabetes Endocrinol
; 8(3): 206-215, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32032540
18.
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87).
Diabetes Res Clin Pract
; 166: 108333, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32702468
19.
Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
Diabetes Care
; 43(9): 2242-2247, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32641379
20.
Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study.
Diabetes Care
; 43(10): 2493-2499, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32801130